Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

224
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
224
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

269
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
269
Autoimmune Disorders01:29

Autoimmune Disorders

1.7K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.7K
Hepatic Portal System01:21

Hepatic Portal System

5.7K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.7K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

562
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
562
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

306
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
306

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast Cancer and Metabolic Dysfunction-Associated Steatotic Liver Disease.

International journal of molecular sciences·2026
Same author

Prevalence and Association of Liver Steatosis and Non-Alcoholic Pancreatic Steatosis in Very High Cardiovascular Risk.

Diseases (Basel, Switzerland)·2026
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease after Pancreatoduodenectomy: an Underestimated Metabolic Complication Driven by Unique Pathophysiological Mechanisms.

Journal of gastrointestinal cancer·2026
Same author

Bariatric Surgery in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: Long-Term Benefits for Liver Health.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Mini-Review: The Detoxification Effects of Black Radish in Metabolically Dysfunctional-Associated Fatty Liver Disease.

International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition·2026
Same author

Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond.

Journal of clinical and experimental hepatology·2025
Same journal

Pragmatism should not eclipse validation in expanded HBV management for Latin America: response.

Annals of hepatology·2026
Same journal

Alcohol-associated liver disease in Asian Americans: the case for disaggregated analysis.

Annals of hepatology·2026
Same journal

Asia-Pacific perspectives on the steatotic liver disease (SLD) reclassification: balancing terminology, diagnostic criteria, and implementation.

Annals of hepatology·2026
Same journal

Alcohol-associated liver disease in the MENA region: A 16-country survey of healthcare provider perspectives.

Annals of hepatology·2026
Same journal

Stem cell therapies for liver cirrhosis: a GRADE evaluation through a systematic review.

Annals of hepatology·2026
Same journal

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Annals of hepatology·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits
04:29

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits

Published on: December 13, 2024

1.2K

Pregnancy and autoimmune hepatitis.

Misael Uribe1, Norberto C Chavez-Tapia, Nahum Mendez-Sanchez

  • 1Department of Gastroenterology, Instituto Nacional de Cienccias Médicas y Nutrición Salvador Zubirán, Tlalpan, México.

Annals of Hepatology
|October 25, 2006
PubMed
Summary
This summary is machine-generated.

Autoimmune hepatitis in pregnancy is rare but manageable. Close monitoring and expert medical care lead to good outcomes for well-controlled patients.

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.4K
A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
07:04

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse

Published on: October 24, 2017

8.9K

Related Experiment Videos

Last Updated: Jan 28, 2026

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits
04:29

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits

Published on: December 13, 2024

1.2K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.4K
A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
07:04

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse

Published on: October 24, 2017

8.9K

Area of Science:

  • Hepatology
  • Immunology
  • Obstetrics

Background:

  • Autoimmune hepatitis (AIH) is a rare liver disease, more prevalent in women.
  • The concurrence of AIH and pregnancy is infrequent.
  • This clinical intersection necessitates specialized knowledge for optimal patient outcomes.

Purpose of the Study:

  • To review key considerations for managing autoimmune hepatitis during pregnancy.
  • To provide guidance for gastroenterologists and hepatologists managing pregnant patients with AIH.
  • To highlight the importance of multidisciplinary care in liver and pregnancy symposiums.

Main Methods:

  • Literature review on autoimmune hepatitis and pregnancy.
  • Clinical case discussions and expert consensus from a symposium.
  • Synthesis of current knowledge on medical management and prognosis.

Main Results:

  • Pregnancy in women with AIH is uncommon.
  • Prognosis is favorable for patients with well-controlled AIH under close medical supervision.
  • Effective management requires a deep understanding of the disease course and treatment options.

Conclusions:

  • Autoimmune hepatitis and pregnancy require careful management by specialists.
  • With proper monitoring and treatment, outcomes for pregnant individuals with AIH are generally positive.
  • This review underscores the need for collaboration between hepatologists and gynecologists.